CARA News and Press, Cara Therapeutics Inc. From 10/01/20

STAMFORD, Conn., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, today announ...

Image source: The Motley Fool. Cara Therapeutics Inc   (NASDAQ: CARA) Q2 2020 Earnings Call Aug 10, 2020 , 6:30 p.m. ET Operator Continue reading

Cara Therapeutics, Inc. (CARA) Q2 2020 Earnings Conference Call August 10, 2020 04:30 PM ET Company Participants Jack Hildick-Smith - Stern IR Derek Chalmers - President and CEO Rick Makara - VP and Head, Accounting Conference Call Participants Chris Howerton - Jefferies ...

Cara Therapeutics (NASDAQ: CARA ) : Q2 GAAP EPS of -$0.54 beats by $0.12 . Revenue of $5.63M (+8.3% Y/Y) beats by $0.57M . Press Release More news on: Cara Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,

– Conference call today at 4:30 p.m. ET – STAMFORD, Conn., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively t...

STAMFORD, Conn., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs, tod...

STAMFORD, Conn., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs, today ann...

Will These Pot Stocks Survive The Cannabis Industry In the Long Term As we search the cannabis industry for marijuana stocks to watch, finding the right ones can be difficult. Which pot stock has all the right financials and future plans on tap? Which pot stock will be able to survive with...

There's a number of upcoming catalysts in the liver disease treatment space, prompting Needham to update its takes on drugmakers targeting the diseases. More news on: Intercept Pharmaceuticals, Inc., Albireo Pharma, Inc., Mirum Pharmaceuticals, Inc., Healthcare stocks news, Notable Calls ...

STAMFORD, Conn., June 30, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs, today an...